MyBiotech GmbH is a Germany-based CDMO specialising in the development and GMP manufacturing of advanced drug products, including nanoparticle-based and conventional parenteral formulations.

We support pharmaceutical and biotech companies from early formulation and process development through scale-up, clinical trial material manufacturing, aseptic fill & finish, lyophilisation, quality control and stability studies. Our expertise includes lipid nanoparticles, polymeric nanoparticles, liposomes, nanoemulsions and other complex drug-delivery systems.

With flexible batch sizes, integrated GMP services and strong expertise in nanomedicine, MyBiotech helps transform innovative formulations into reliable, scalable products for preclinical and clinical development.